What does DATWYLER PHARMA PACKAGING BELGIUM do?

DATWYLER PHARMA PACKAGING BELGIUM is a plastics manufacturer in Alken. Public Limited, started on 16 August 1989, 1 establishment.

What is the address of DATWYLER PHARMA PACKAGING BELGIUM?

The registered office of DATWYLER PHARMA PACKAGING BELGIUM is located at Industrieterrein Kolmen 1519, 3570 Alken.

Is DATWYLER PHARMA PACKAGING BELGIUM still active?

Yes. According to the CBE (29 October 2026) DATWYLER PHARMA PACKAGING BELGIUM is active, legal situation “Normale toestand”, started on 16 August 1989.

Is DATWYLER PHARMA PACKAGING BELGIUM registered on Peppol?

Yes, DATWYLER PHARMA PACKAGING BELGIUM is registered on the Peppol network with ID 0208:0438160084.

What is the enterprise number of DATWYLER PHARMA PACKAGING BELGIUM?

The enterprise number of DATWYLER PHARMA PACKAGING BELGIUM is BE0438160084.

When was DATWYLER PHARMA PACKAGING BELGIUM founded?

DATWYLER PHARMA PACKAGING BELGIUM was founded on 16 August 1989.

Who are the directors of DATWYLER PHARMA PACKAGING BELGIUM?

According to the 2025 annual accounts, the directors of DATWYLER PHARMA PACKAGING BELGIUM are: Judith van Walsum, Jurgen Steyls, Loic Kistler, Dirk Borghs.

Is DATWYLER PHARMA PACKAGING BELGIUM a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 16 August 1989; 5 annual accounts filed, latest fiscal year 2025; 4 directors known from the annual account.

How much profit did DATWYLER PHARMA PACKAGING BELGIUM make in 2025?

DATWYLER PHARMA PACKAGING BELGIUM posted a profit after taxes of € 53,689,748 in financial year 2025.

What is the revenue of DATWYLER PHARMA PACKAGING BELGIUM?

In its most recent annual accounts (2025), DATWYLER PHARMA PACKAGING BELGIUM reported revenue of € 190,135,940.

How much does an employee at DATWYLER PHARMA PACKAGING BELGIUM earn?

The average wage cost per full-time employee at DATWYLER PHARMA PACKAGING BELGIUM was € 100,500 in 2025: staff costs of € 66.9 million for 665.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does DATWYLER PHARMA PACKAGING BELGIUM have?

According to the 2025 annual accounts, DATWYLER PHARMA PACKAGING BELGIUM has 665.6 full-time equivalents (FTE).

DATWYLER PHARMA PACKAGING BELGIUM (Public Limited)

Dossier DATWYLER PHARMA PACKAGING BELGIUM, printed on 29 October 2026 from databakkes.be/en/0438160084/datwyler-pharma-packaging-belgium. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DATWYLER PHARMA PACKAGING BELGIUM from Alken, company number BE0438160084, closed financial year 2025 with a result of € 53.7 million after tax. For that financial year DATWYLER PHARMA PACKAGING BELGIUM recorded revenue of € 190.1 million and equity of € 73.7 million. Compared with financial year 2024, the result moved from € -84.8 million to € 53.7 million. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on May 7, 2026.

What it is worth Growing

€ 73.7 million

▲ 23% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 53.7 million

▲ still € 84.8 million loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 2.5 million

▲ 83% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 40 million paid out

75 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

665.6

▼ 11.3 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost Staff costs are payroll only. Director pay sits with services and miscellaneous goods: € 65.4 million in 2025, together with rent, insurance, accountants and other services. The accounts do not split that further.

€ 66.9 million

▲ 5% vs 2024

€ 100,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 474,716

▼ 16% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 63 million

▼ 43% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 20 million

▼ 11% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 70 days on average.

Taxes and wages

€ 9.5 million

▲ 10% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 196,916,614 Revenue 2022: € 196,916,614 First fiscal year in the series	€ 196,562,157 Revenue 2023: € 196,562,157 Unchanged (€ 196,916,614) Unfavourable step	€ 174,794,955 Revenue 2024: € 174,794,955 ▼ 11% vs 2023 (€ 196,562,157) Unfavourable step	€ 190,135,940 Revenue 2025: € 190,135,940 ▲ 9% vs 2024 (€ 174,794,955) Favourable step	▲ 9%
Profit after taxes	€ 43,421,694 Profit after taxes 2022: € 43,421,694 First fiscal year in the series	€ 39,436,006 Profit after taxes 2023: € 39,436,006 ▼ 9% vs 2022 (€ 43,421,694) Unfavourable step	€ -84,794,232 Profit after taxes 2024: € -84,794,232 ▼ € 124.2 million vs 2023 (€ 39,436,006) Unfavourable step	€ 53,689,748 Profit after taxes 2025: € 53,689,748 ▲ € 138.5 million vs 2024 (€ -84,794,232) Favourable step	▲ € 138.5 million
Equity	€ 145,316,647 Equity 2022: € 145,316,647 First fiscal year in the series	€ 144,658,073 Equity 2023: € 144,658,073 Unchanged (€ 145,316,647) Unfavourable step	€ 60,116,957 Equity 2024: € 60,116,957 ▼ 58% vs 2023 (€ 144,658,073) Unfavourable step	€ 73,666,848 Equity 2025: € 73,666,848 ▲ 23% vs 2024 (€ 60,116,957) Favourable step	▲ 23%
Total debts	€ 119,628,020 Total debts 2022: € 119,628,020 First fiscal year in the series	€ 112,873,933 Total debts 2023: € 112,873,933 ▼ 6% vs 2022 (€ 119,628,020) Favourable step	€ 145,102,795 Total debts 2024: € 145,102,795 ▲ 29% vs 2023 (€ 112,873,933) Unfavourable step	€ 137,524,252 Total debts 2025: € 137,524,252 ▼ 5% vs 2024 (€ 145,102,795) Favourable step	▼ 5%
Cash	€ 2,270,878 Cash 2022: € 2,270,878 First fiscal year in the series	€ 1,927,448 Cash 2023: € 1,927,448 ▼ 15% vs 2022 (€ 2,270,878) Unfavourable step	€ 1,372,143 Cash 2024: € 1,372,143 ▼ 29% vs 2023 (€ 1,927,448) Unfavourable step	€ 2,517,803 Cash 2025: € 2,517,803 ▲ 83% vs 2024 (€ 1,372,143) Favourable step	▲ 83%
Land & buildings	€ 11,865,563 Land & buildings 2022: € 11,865,563 First fiscal year in the series	€ 10,903,379 Land & buildings 2023: € 10,903,379 ▼ 8% vs 2022 (€ 11,865,563) Unchanged	€ 9,615,441 Land & buildings 2024: € 9,615,441 ▼ 12% vs 2023 (€ 10,903,379) Unchanged	€ 13,280,164 Land & buildings 2025: € 13,280,164 ▲ 38% vs 2024 (€ 9,615,441) Unchanged	▲ 38%
Retained profit	€ 126,869,141 Retained profit 2022: € 126,869,141 First fiscal year in the series	€ 126,305,147 Retained profit 2023: € 126,305,147 Unchanged (€ 126,869,141) Unfavourable step	€ 41,510,915 Retained profit 2024: € 41,510,915 ▼ 67% vs 2023 (€ 126,305,147) Unfavourable step	€ 55,200,663 Retained profit 2025: € 55,200,663 ▲ 33% vs 2024 (€ 41,510,915) Favourable step	▲ 33%
Dividend	€ 48,000,000 Dividend 2022: € 48,000,000 First fiscal year in the series	€ 40,000,000 Dividend 2023: € 40,000,000 ▼ 17% vs 2022 (€ 48,000,000) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 40,000,000) Unchanged	€ 40,000,000 Dividend 2025: € 40,000,000 Unchanged (€ 0) Unchanged
Bank debt	€ 38,000,000 Bank debt 2022: € 38,000,000 First fiscal year in the series	€ 38,000,000 Bank debt 2023: € 38,000,000 Unchanged (€ 38,000,000) Unchanged	€ 110,500,000 Bank debt 2024: € 110,500,000 ▲ 191% vs 2023 (€ 38,000,000) Unfavourable step	€ 63,000,000 Bank debt 2025: € 63,000,000 ▼ 43% vs 2024 (€ 110,500,000) Favourable step	▼ 43%
Balance sheet total	€ 266,072,262 Balance sheet total 2022: € 266,072,262 First fiscal year in the series	€ 258,406,930 Balance sheet total 2023: € 258,406,930 ▼ 3% vs 2022 (€ 266,072,262) Unchanged	€ 206,564,122 Balance sheet total 2024: € 206,564,122 ▼ 20% vs 2023 (€ 258,406,930) Unchanged	€ 212,428,827 Balance sheet total 2025: € 212,428,827 ▲ 3% vs 2024 (€ 206,564,122) Unchanged	▲ 3%
Employees (FTE)	702 Employees (FTE) 2022: 702 First fiscal year in the series	704 Employees (FTE) 2023: 704 ▲ 2 vs 2022 (702) Unchanged	676.9 Employees (FTE) 2024: 676.9 ▼ 27.1 vs 2023 (704) Unchanged	665.6 Employees (FTE) 2025: 665.6 ▼ 11.3 vs 2024 (676.9) Unchanged	▼ 11.3

Key figures of DATWYLER PHARMA PACKAGING BELGIUM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DATWYLER PHARMA PACKAGING BELGIUM?

What happened at DATWYLER PHARMA PACKAGING BELGIUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2027 Judith van Walsum stepped down as director. NBB
2027 Jurgen Steyls stepped down as director. NBB
May 7, 2026 New annual accounts for financial year 2025: profit of € 53.7 million. Source: NBB ↗
2026 Loic Kistler stepped down as director. NBB
2026 Dirk Borghs stepped down as director. NBB
2024 Judith van Walsum became a director. NBB
2024 Jurgen Steyls became a director. NBB
2024 Loic Kistler became a director. NBB

In short

From € 43.4 million profit in 2022 to € 53.7 million profit in 2025.

Paid € 30.2 million in corporate taxes since 2022.

Best year ever: 2025, with € 53.7 million profit.

Paid out € 128 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

DATWYLER PHARMA PACKAGING BELGIUM

DATWYLER PHARMA PACKAGING ITALIA SRL 100%

YANTAI XINHUI PACKING CO. LTD 100%

DATWYLER PHARMA PACKAGING USA INC 100%

DATWYLER SEALING SOLUTIONS DO BRASIL LTDA 0.4%

It owns 100% of DATWYLER PHARMA PACKAGING ITALIA SRL, 100% of YANTAI XINHUI PACKING CO. LTD, 100% of DATWYLER PHARMA PACKAGING USA INC, 0.4% of DATWYLER SEALING SOLUTIONS DO BRASIL LTDA and 0% of DATWYLER PHARMA PACKAGING INDIA PRIVATE LIMITED itself.

Directors

According to the 2025 annual accounts

Judith van Walsum

Bestuurder

since 2024 · until 2027

Jurgen Steyls

Bestuurder

since 2024 · until 2027

Loic Kistler

Bestuurder

since 2024 · until 2026

Dirk Borghs

Bestuurder

Also active at: TARGET FOODS

since 2024 · until 2026

Establishments

Establishment units

Physical locations of this company

Registered office

Industrieterrein Kolmen 1519

3570 Alken

2.044.875.509

Kolmenstraat 1519

3570 Alken

Active since 22 September 1989

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0438.160.084

VAT number

BE 0438.160.084

Registered office

Industrieterrein Kolmen 1519, 3570 Alken

Names & denominations

DATWYLER PHARMA PACKAGING BELGIUM · DPP BELGIUM

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

16 August 1989

Peppol

Active · Active since 23 Oct 2025

Activities · NACE

Vervaardiging van andere producten van rubber

Vervaardiging van overige producten van rubber

View on CBE Public ↗ Annual accounts (NBB) ↗

DATWYLER PHARMA PACKAGING BELGIUM

Financials

What happened to DATWYLER PHARMA PACKAGING BELGIUM?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions